Legal & General Group Plc decreased its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 2.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,099,432 shares of the company's stock after selling 456,629 shares during the quarter. Procter & Gamble comprises 0.5% of Legal & General Group Plc's investment portfolio, making the stock its 24th largest holding. Legal & General Group Plc owned 0.69% of Procter & Gamble worth $2,307,210,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC raised its position in Procter & Gamble by 51.5% during the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company's stock worth $6,717,000 after buying an additional 13,617 shares during the last quarter. Taylor Financial Group Inc. raised its position in Procter & Gamble by 10.6% during the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company's stock worth $493,000 after buying an additional 277 shares during the last quarter. Sivia Capital Partners LLC raised its position in Procter & Gamble by 19.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company's stock worth $979,000 after buying an additional 1,016 shares during the last quarter. Auxano Advisors LLC raised its position in Procter & Gamble by 10.8% during the 2nd quarter. Auxano Advisors LLC now owns 7,315 shares of the company's stock worth $1,165,000 after buying an additional 714 shares during the last quarter. Finally, Schnieders Capital Management LLC. raised its position in Procter & Gamble by 2.8% during the 2nd quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company's stock worth $4,809,000 after buying an additional 809 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.
Procter & Gamble Stock Performance
Shares of PG opened at $144.50 on Monday. The company has a 50-day simple moving average of $144.93 and a 200-day simple moving average of $147.95. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $336.49 billion, a PE ratio of 21.13, a P/E/G ratio of 6.19 and a beta of 0.41. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $170.99.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.56 by $0.03. The business had revenue of $21.24 billion during the quarter, compared to the consensus estimate of $21.52 billion. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The business's revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Friday, April 24th were issued a dividend of $1.0885 per share. This is an increase from Procter & Gamble's previous quarterly dividend of $1.06. The ex-dividend date was Friday, April 24th. This represents a $4.35 annualized dividend and a yield of 3.0%. Procter & Gamble's payout ratio is 63.60%.
Insiders Place Their Bets
In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 5,549 shares of the firm's stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $165.29, for a total transaction of $917,194.21. Following the completion of the transaction, the chief executive officer directly owned 1,029 shares in the company, valued at approximately $170,083.41. This trade represents a 84.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.20% of the company's stock.
Wall Street Analysts Forecast Growth
PG has been the subject of a number of analyst reports. Wells Fargo & Company upped their price objective on shares of Procter & Gamble from $158.00 to $164.00 and gave the stock an "overweight" rating in a research report on Monday, April 27th. Weiss Ratings restated a "hold (c)" rating on shares of Procter & Gamble in a research report on Friday, March 27th. BNP Paribas Exane cut their price target on shares of Procter & Gamble from $172.00 to $165.00 and set an "outperform" rating for the company in a report on Thursday, April 23rd. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a $163.00 price target on shares of Procter & Gamble in a report on Monday, April 27th. Finally, TD Cowen increased their price target on shares of Procter & Gamble from $142.00 to $150.00 and gave the company a "hold" rating in a report on Monday, April 27th. Eleven research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, Procter & Gamble presently has an average rating of "Moderate Buy" and an average target price of $161.06.
Check Out Our Latest Analysis on PG
Procter & Gamble Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.